Earlier this month, Rocket Lab completed its “Insight At Speed Is A Friend Indeed” mission from New Zealand, deploying a commercial satellite to low Earth orbit just ~6 days after a separate U.S. launch for the Department of War’s Defense Innovation Unit.
The rapid turnaround between government and commercial launches, supported by its Motorized Lightband separation system’s perfect mission record, underlines Rocket Lab’s vertically integrated approach and operational reliability in the small-lift market.
We’ll now examine how this rapid two-continent launch cadence and growing defense work may influence Rocket Lab’s broader investment narrative.
The latest GPUs need a type of rare earth metal called Dysprosium and there are only 28 companies in the world exploring or producing it. Find the list for free.
To own Rocket Lab, you have to believe its vertically integrated model can turn frequent small launches and growing defense work into sustainable, higher-margin space infrastructure revenue, despite ongoing losses and heavy Neutron spend. The back to back government and commercial launches across two continents reinforce execution on the launch side, but they do not materially change the near term Neutron development delay, which still looks like the key catalyst and central execution risk.
In this context, Rocket Lab’s record 2025 revenue and US$1.85 billion backlog, including the US$816 million Space Development Agency contract, feel especially relevant. The latest mission underlines why defense agencies and constellation operators may value its integrated launch plus space systems offering, but it also highlights the flip side of that backlog reliance, where program timing and Neutron progress can quickly influence how those awards translate into revenue and cash flow.
Yet beneath the impressive launch tempo, investors should be aware that Neutron’s delayed first flight and cash burn could still…
Read the full narrative on Rocket Lab (it’s free!)
Rocket Lab’s narrative projects $1.3 billion revenue and $113.4 million earnings by 2028.
Uncover how Rocket Lab’s forecasts yield a $89.88 fair value, a 26% upside to its current price.
RKLB 1-Year Stock Price Chart
While consensus focuses on steady backlog growth, the most optimistic analysts saw revenue hitting about US$1.5 billion and earnings turning positive by 2028, showing how differently you might weigh Neutron’s upside versus its execution risk after news like this.
Explore 62 other fair value estimates on Rocket Lab – why the stock might be worth as much as 68% more than the current price!
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
Opportunities like this don’t last. These are today’s most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include RKLB.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com